{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:32:58Z","timestamp":1748320378445,"version":"3.40.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100014996","name":"Health and Family Planning Commission of Zhejiang Province","doi-asserted-by":"crossref","award":["2017KY002"],"award-info":[{"award-number":["2017KY002"]}],"id":[{"id":"10.13039\/501100014996","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial National Science Foundation","award":["LQ19H090006"],"award-info":[{"award-number":["LQ19H090006"]}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"crossref","award":["2018ZA001"],"award-info":[{"award-number":["2018ZA001"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Anticoagulant treatment increases the risk of intracerebral hemorrhage (ICH), but whether the treatment, more specifically non-vitamin K oral anticoagulants (NOACs), increases the risk of cerebral microbleeds (CMBs) remains uncertain. We performed this study to investigate the development of new CMBs due to NOACs or warfarin treatment in patients with atrial fibrillation (AF).<\/jats:p>\n            <jats:p>We prospectively recruited AF patients before anticoagulation from June 2016 to June 2018. We performed susceptibility-weighted imaging (SWI) examinations on all enrolled AF patients and re-examined SWI 1 year later. We compared demographic features and new CMBs between the NOACs group and the warfarin group. Univariate analysis of clinical factors was performed according to the development of new CMBs; and age, a HAS-B(L)ED score, warfarin use, and the presence of baseline CMBs were then selected for inclusion in the multivariate logistic regression model.<\/jats:p>\n            <jats:p>A total of 72 AF patients were recruited, 29 of whom were assigned to the NOACs group and 43 to the warfarin group. Finally, 1 patient in the NOACs group (3.4%) and 9 patients (20.9%) in the warfarin group developed new CMBs after 1\u200ayear follow-up (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.08). Univariate analysis showed that age, a HAS-B(L)ED score \u22654, the presence of baseline CMBs were associated with the development of new CMBs (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05). And multivariate regression analysis showed baseline CMBs (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.03, odds ratio\u200a=\u200a6.37, 95% confidence interval 1.15\u201335.36) was independently related to the increase in new CMBs.<\/jats:p>\n            <jats:p>AF patients treated with NOACs may have a decreased trend in the development of new CMBs compared with those treated with warfarin. Baseline CMBs increased the frequency of new CMBs during anticoagulant treatment. The development of new CMBs in AF patients with anticoagulation requires further longitudinal studies with longer follow-up in larger samples.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025836","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:07:55Z","timestamp":1648825675000},"page":"e25836","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["New cerebral microbleeds in AF patients on non-vitamin K oral anticoagulants or warfarin"],"prefix":"10.1097","volume":"101","author":[{"given":"Liying","family":"Zhuang","sequence":"first","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihao","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zhejiang Hospital, Hangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilun","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengli","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-3471","authenticated-orcid":false,"given":"Junjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhejiang Hospital, Hangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka","year":"2006","journal-title":"Circulation"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","article-title":"Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study","volume":"36","author":"Marini","year":"2005","journal-title":"Stroke"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/heartjnl-2013-304347","article-title":"Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients","volume":"100","author":"Dogliotti","year":"2014","journal-title":"Heart"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/01.WNL.0000101463.50798.0D","article-title":"Cerebral microbleeds are regionally associated with intracerebral hemorrhage","volume":"62","author":"Lee","year":"2004","journal-title":"Neurology"},{"key":"R9-20250504","first-page":"573","article-title":"MR of cerebral abnormalities concomitant with primary intracerebral hematomas","volume":"17","author":"Offenbacher","year":"1996","journal-title":"AJNR Am J Neuroradiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11883-015-0524-7","article-title":"Anticoagulation for atrial fibrillation in patients with cerebral microbleeds","volume":"17","author":"Wilson","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.STR.0000126807.69758.0e","article-title":"Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage","volume":"35","author":"Greenberg","year":"2004","journal-title":"Stroke"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/STROKEAHA.109.572594","article-title":"Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies","volume":"41","author":"Lovelock","year":"2010","journal-title":"Stroke"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jnnp-2018-319104","article-title":"Risk of intracerebral haemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-Warfarin study","volume":"90","author":"Soo","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/STROKEAHA.119.028030","article-title":"Oral anticoagulation in Asian patients with atrial fibrillation and a history of intracranial hemorrhage","volume":"51","author":"Lee","year":"2020","journal-title":"Stroke"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.018","article-title":"Non-vitamin k antagonist oral anticoagulants do not increase cerebral microbleeds","volume":"24","author":"Saito","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.03.050","article-title":"Effectiveness of nonvitamin K antagonist oral anticoagulants and warfarin for preventing further cerebral microbleeds in acute ischemic stroke patients with nonvalvular atrial fibrillation and at least one microbleed: CMB-NOW Multisite Pilot Trial","volume":"28","author":"Yokoyama","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3174\/ajnr.A4248","article-title":"SWI or T2\u2217: which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska Imaging Dementia Study","volume":"36","author":"Shams","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/clc.22294","article-title":"Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2, CHA2 DS2 -VASc, R2 CHADS2, HAS-BLED, ATRIA, and more)","volume":"37","author":"Dzeshka","year":"2014","journal-title":"Clin Cardiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.clineuro.2013.03.004","article-title":"New cerebral microbleeds in ischemic stroke patients on warfarin treatment: two-year follow-up","volume":"115","author":"Orken","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/STROKEAHA.110.607184","article-title":"Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study","volume":"42","author":"Poels","year":"2011","journal-title":"Stroke"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1468-1331.2012.03776.x","article-title":"Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates","volume":"19","author":"De Reuck","year":"2012","journal-title":"Eur J Neurol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/WCO.0000000000000411","article-title":"Antithrombotic therapy in patients with cerebral microbleeds","volume":"30","author":"Wilson","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/jnnp-2017-317151","article-title":"Correlation of non-vitamin K antagonist oral anticoagulant exposure and cerebral microbleeds in Chinese patients with atrial fibrillation","volume":"89","author":"Soo","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/acn3.50834","article-title":"Microbleed prevalence and burden in anticoagulant-associated intracerebral bleed","volume":"6","author":"Lioutas","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R27-20250504","first-page":"268","article-title":"Use of anticoagulant therapy and cerebral microbleeds: a systematic review and meta-analysis","volume":"5","author":"Cheng","year":"2021","journal-title":"J Neurol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000331466","article-title":"Cerebral microbleeds: histopathological correlation of neuroimaging","volume":"32","author":"Shoamanesh","year":"2011","journal-title":"Cerebrovasc Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1212\/WNL.0000000000004259","article-title":"Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/STROKEAHA.109.568469","article-title":"MRI detection of new microbleeds in patients with ischemic stroke: five-year cohort follow-up study","volume":"41","author":"Gregoire","year":"2010","journal-title":"Stroke"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1212\/WNL.0000000000008735","article-title":"Cerebral microbleed incidence, relationship to amyloid burden: the Mayo Clinic Study of Aging","volume":"94","author":"Graff-Radford","year":"2020","journal-title":"Neurology"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0b013e3181e396ea","article-title":"Incidence of cerebral microbleeds: a longitudinal study in a memory clinic population","volume":"74","author":"Goos","year":"2010","journal-title":"Neurology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:22:28Z","timestamp":1746332548000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025836"}},"subtitle":["One-year follow-up"],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025836","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"assertion":[{"value":"2020-07-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}